Stockreport

IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 [Yahoo! Finance]

Imunon, Inc.  (IMNN) 
PDF LAWRENCEVILLE, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- IMUNON , Inc. (NASDAQ: IMNN) , a clinical-stage drug-development company focused on developing non-viral DNA-med [Read more]